Ristomycin monosulfate
SIGMA/R7752 - ≥90% ristocetin A basis (balance primarily Ristocetin B)
Synonym: Ristocetin sulfate salt
CAS Number: 11140-99-1
Empirical Formula (Hill Notation): C95H110N8O44 · H2SO4
Molecular Weight: 2166.00
MDL Number: MFCD00076121
Linear Formula: C95H110N8O44 · H2SO4
Product Type: Chemical
| assay | ≥90% ristocetin A basis (balance primarily Ristocetin B) |
| InChI | 1S/C95H110N8O44/c1-30-47( |
| InChI key | VUOPFFVAZTUEGW-ZNAZZOOYSA |
| mode of action | cell wall synthesis | interferes |
| Quality Level | 200 ![]() |
| SMILES string | COC(=O)[C@@H]1NC(=O)[C@H] |
| storage temp. | 2-8°C |
| Application: | Ristomycin monosulfate has been used: • to activate platelet and induce platelet aggregation • to study the aggregation responses of platelets from buffalo, horse, pig and sheep • in in-house ristocetin cofactor von Willebrand factor (VWF:RCo) assay to measure glycoprotein Ib (GpIb) binding activity |
| Biochem/physiol Actions: | Ristocetin activates platelets. Ristocetin-induced platelet agglutination (RIPA) is decreased in patients undergoing chronic hemodialysis. Together with increased plasma glycocalicin levels (a product of enzymatic cleavage of GPIb), RIPA may contribute to diminished platelet adhesion to vascular subendothelium and increased bleeding associated with uremia. Addition of ristocetin and vWf caused specific agglutination of rGPIbα-liposomes suporting the potential use of rGPIbα-liposomes to enhance platelet function in vivo and support hemostasis in thrombocytopenic individuals. |
| Biochem/physiol Actions: | Ristomycin possesses antibacterial activity. It may be used to diagnose von Willebrand disease and Bernard-Soulier syndrome. Ristocetin-induced platelet agglutination (RIPA) is decreased in patients undergoing chronic hemodialysis. Increased plasma glycocalicin levels (a product of enzymatic cleavage of GPIb) and decreased RIPA might reduce platelet adhesion to vascular subendothelium and improve bleeding associated with uremia in patients with chronic hemodialysis. |
| General description: | Ristomycin/ristocetin is a type III glycopeptide. It is a highly glycosylated glycopeptide, previously found in Amycolatopsis lurida. |
| Other Notes: | Glycopeptide antibiotic complex |
| Packaging: | 100, 250 mg in poly bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥90% ristocetin A basis (balance primarily Ristocetin B) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352202 |

